SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SAMRAT PHARMACHEM

BSE: 530125 28 Jun 2025
Healthcare
₹ 344
Samrat Pharmachem Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SAMRAT PHARMACHEM - Share Price & Details

Market Cap
₹112.0
High /Low
646.0 / 302.0
Stock P/E
15.7
Book Value
₹232.0
Dividend Yield
0.28
ROCE
13.6
ROE
₹10.4
Face Value
10.0
PEG Ratio
1.45
EVEBITDA
₹10.8
Debt
9.91
CMP / FCF
-26.6
Debt to equity
₹0.14
NP Ann
7.11
High price all time
1,250
Piotroski score
₹6.0
Graham Number
347.0
No. Eq. Shares
0.31
Net CF
₹-9.62
Net profit
7.11
Price to book value
1.55
Interest Coverage
₹15.8
Low price all time
6.21
Industry PE
32.7
Reserves
₹68.7
Free Cash Flow
₹-10.6

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
SAMRAT PHARMACHEM LTD.NANANANA112.015.7
BHARAT IMMUNOLOGICALS & BIOLOGNANANANA109
Rajnish Wellness LimitedNANANANA108635.0

Peer Comparison Chart


About SAMRAT PHARMACHEM

Samrat Pharmachem Ltd., with Security Code 530125, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Samrat Pharmachem Share Price Today 11 Jun 2025: Live NSE/BSE Rates, Technical Analysis and Expert Forecasts

(09 Jun 2025)
Samrat Pharmachem Limited is an India-based manufacturer of iodine salts. The Company is engaged in the business of pharmaceutical chemicals...
Read more →

Samrat Pharmachem Faces Financial Challenges Amidst Strong Management Efficiency Metrics

(03 Jun 2025)
Samrat Pharmachem, a microcap in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment reflecting changes in its...
Read more →

Samrat Pharmachem Reports Declining Profitability Metrics in March 2025 Results

(31 May 2025)
Samrat Pharmachem has announced its financial results for the quarter ending March 2025, showing significant declines in profitability...
Read more →

Samrat Pharmachem's Evaluation Adjusted Amid Mixed Technical Signals and Strong Financial Performance

(22 Apr 2025)
Samrat Pharmachem, a microcap in the Pharmaceuticals & Drugs sector, has experienced a recent evaluation adjustment. This change considers the company's...
Read more →

Are Infinium Pharmachem Limited's (NSE:INFINIUM) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

(08 Apr 2025)
Infinium Pharmachem (NSE:INFINIUM) has had a rough three months with its share price down 29%. But if you pay close...
Read more →

Samrat Pharmachem Faces Significant Volatility Amidst Broader Market Recovery

(08 Apr 2025)
Samrat Pharmachem, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility.
Read more →